SINGAPORE (Dec 24): The US economy enjoyed one of its most robust performances when it reported its fastest rate of GDP growth in nearly four years in 2Q2018. The strong growth, which was driven by higher fiscal spending and tax cuts, should have extended the bullish run seen in US equities over the last few years. Instead, trade tensions with China and fears of a US slowdown have taken the wind out of the sails for US equities.

It is, then, perhaps surprising that the top-performing Singapore-registered funds in 2018 are dominated by those that largely invest in US equities, according to Morningstar data. Among these funds, the crème de la crème are those that have high exposure to the healthcare sector.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook